Acetylcholine — Current Status in Physiology, Pharmacology and Medicine
- 18 May 1972
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 286 (20) , 1086-1090
- https://doi.org/10.1056/nejm197205182862006
Abstract
IT is now just over half a century since Otto Loewi provided the first conclusive evidence of the humoral, or chemical, transmission of nerve impulses, a concept that had been suggested by DuBois-Reymond nearly half a century previously. Loewi and his associates went on to show that the neurohumoral transmitter in the system he employed, the cardiac vagus of the frog, is acetylcholine (ACh, [CH3]3N+CH2OCOCH3), that an enzyme, subsequently termed cholinesterase, terminates the vagal action by hydrolyzing the transmitter, and that the alkaloidal drug, physostigmine, produces its vagomimetic effect by inhibiting the . . .Keywords
This publication has 30 references indexed in Scilit:
- SPONTANEOUS END‐PLATE ACTIVITY IN NORMAL SUBJECTS AND IN PATIENTS WITH MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1971
- Proteins in Excitable MembranesScience, 1970
- Choline acetyltransferase inhibitors. Configurational and electronic features of styrylpyridine analogsJournal of Medicinal Chemistry, 1969
- Functional Anatomy of Synaptic TransmissionAnesthesiology, 1968
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967
- Anticholinesterase Drugs and CataractsAmerican Journal of Ophthalmology, 1966
- THE FREQUENCY OF CATARACT AFTER MIOTIC THERAPYActa Ophthalmologica, 1966
- The Physiology of SynapsesPublished by Springer Nature ,1964
- The Active Site of Acetylcholinesterase and Related Esterases and its Reactivity towards Substrates and InhibitorsPublished by Springer Nature ,1963
- Nature and Spatial Relationship of the Prosthetic Chemical Groups Required for Maximal Muscarinic ActionScience, 1948